Brief: Mainz Biomed And Oncovanguard8 Enter Into Agreement To Bring Coloalert To South America
18/11/2025 13:16
Mainz Biomed NV 4TO.F: MAINZ BIOMED AND ONCOVANGUARD8 ENTER INTO AGREEMENT TO BRING COLOALERT TO SOUTH AMERICA Source text: ID:nGNX5ngdFN Further company coverage: 4TO.F
Recent news on Quantum Cyber NV
See all newsBrief: Quantum Cyber To Proceed With Pending Litigation Against Adam Gefvert
Brief: Quantum Cyber NV Files Lawsuit Against White Diamond Research, Adam Gefvert And Stocktwits, Inc. In New York Supreme Court
Quantum Cyber jumps on SpaceX stake purchase plan
Brief: Quantum Cyber Signs Loi To Acquire An Estimated 43,000 Square Foot U.S.-Based Manufacturing Facility To Support Mass-Scale Autonomous Drone Production
Brief: Quantum Cyber NV - To Terminate ATM Sales Agreement With Maxim Effective June 7, 2026 - SEC Filing